|
HY-P0154-10mg
|
MedChemexpress LLC
|
Epsilon-V1-2 [CAS 182683-50-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0154-25mg
|
MedChemexpress LLC
|
Epsilon-V1-2 [CAS 182683-50-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0154-5mg
|
MedChemexpress LLC
|
Epsilon-V1-2 [CAS 182683-50-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0238-1mg
|
MedChemexpress LLC
|
Gastrin-Releasing Peptide, human [CAS 93755-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P0238-10mg
|
MedChemexpress LLC
|
Gastrin-Releasing Peptide, human [CAS 93755-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P0238-5mg
|
MedChemexpress LLC
|
Gastrin-Releasing Peptide, human [CAS 93755-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P0238-500ug
|
MedChemexpress LLC
|
Gastrin-Releasing Peptide, human [CAS 93755-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P1110-1mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1110-5mg
|
MedChemexpress LLC
|
AF12198 [CAS 185413-30-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1136B-1mg
|
MedChemexpress LLC
|
TAT-Gap19 [CAS 1507930-54-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1136B-5mg
|
MedChemexpress LLC
|
TAT-Gap19 [CAS 1507930-54-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1137-1mg
|
MedChemexpress LLC
|
10Panx [CAS 955091-53-9]
|
|
|
|
|
HY-P1137-10mg
|
MedChemexpress LLC
|
10Panx [CAS 955091-53-9]
|
|
|
|
|
HY-P1137-5mg
|
MedChemexpress LLC
|
10Panx [CAS 955091-53-9]
|
|
|
|
|
HY-P1701-1mg
|
MedChemexpress LLC
|
Morphiceptin [CAS 74135-04-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1701-10mg
|
MedChemexpress LLC
|
Morphiceptin [CAS 74135-04-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1701-5mg
|
MedChemexpress LLC
|
Morphiceptin [CAS 74135-04-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1798-1mg
|
MedChemexpress LLC
|
Platelet Factor 4 (58-70), human [CAS 82989-21-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1798-10mg
|
MedChemexpress LLC
|
Platelet Factor 4 (58-70), human [CAS 82989-21-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1798-5mg
|
MedChemexpress LLC
|
Platelet Factor 4 (58-70), human [CAS 82989-21-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2459-1mg
|
MedChemexpress LLC
|
MOG (35-55), human [CAS 163158-19-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2459-10mg
|
MedChemexpress LLC
|
MOG (35-55), human [CAS 163158-19-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2459-5mg
|
MedChemexpress LLC
|
MOG (35-55), human [CAS 163158-19-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1136A-1mg
|
MedChemexpress LLC
|
Gap19 (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1136A-10mg
|
MedChemexpress LLC
|
Gap19 (TFA)
|
|
COVID-19-immunoregulation
|
|
